data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Kymera Therapeutics
(NASDAQ:KYMR)
20.73
0.60[2.98%]
At close: Jun 27
20.73
00
After Hours: 4:02PM EDT
Day High/Low19.54 - 21.21
52 Week High/Low13.15 - 69.12
Open / Close20.1 / 20.73
Float / Outstanding40.7M / 51.7M
Vol / Avg.639K / 743.8K
Mkt Cap1.1B
P/E-
50d Avg. Price20.54
Div / Yield-
Payout Ratio-
EPS-0.71
Total Float40.7M

Kymera Therapeutics (NASDAQ:KYMR), Quotes and News Summary

Kymera Therapeutics (NASDAQ: KYMR)

Day High/Low19.54 - 21.21
52 Week High/Low13.15 - 69.12
Open / Close20.1 / 20.73
Float / Outstanding40.7M / 51.7M
Vol / Avg.639K / 743.8K
Mkt Cap1.1B
P/E-
50d Avg. Price20.54
Div / Yield-
Payout Ratio-
EPS-0.71
Total Float40.7M
Benzinga - Jun 15, 2022, 8:55AM
Benzinga - Jun 15, 2022, 7:01AM
Benzinga - Jun 1, 2022, 10:37AM
Benzinga - Jun 1, 2022, 8:22AM
Benzinga - Jun 1, 2022, 7:01AM
Benzinga - May 31, 2022, 9:11PM
Benzinga - May 31, 2022, 9:06PM
Benzinga - May 23, 2022, 8:05AM
Benzinga - May 20, 2022, 7:32AM
Benzinga - May 10, 2022, 9:24AM
Benzinga - May 5, 2022, 8:13AM
Benzinga - May 4, 2022, 10:53AM
Benzinga - May 4, 2022, 10:07AM
Benzinga - May 3, 2022, 2:18PM
Benzinga - May 3, 2022, 11:15AM
Benzinga - May 3, 2022, 7:40AM
load more
Sector: Health Care.Industry: Biotechnology
Kymera Therapeutics Inc is a biotechnology company pioneering a transformative new approach to treating previously untreatable diseases. The company is advancing the field of targeted protein degradation, accessing the body's innate protein recycling machinery to degrade dysregulated, disease-causing proteins. Kymera's Pegasus targeted protein degradation platform harnesses the body's natural protein recycling machinery to degrade disease-causing proteins, with a focus on un-drugged nodes in validated pathways currently inaccessible with conventional therapeutics. It is accelerating drug discovery with an unmatched ability to target and degrade intractable proteins and advance new treatment options for patients.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-05
REV
Q1 2022Est.ActualSurprise
EPS-0.660-0.710 -0.0500
REV16.230M9.622M-6.608M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Kymera Therapeutics Questions & Answers

Q
How do I buy Kymera Therapeutics (KYMR) stock?
A

You can purchase shares of Kymera Therapeutics (NASDAQ: KYMR) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Kymera Therapeutics's (KYMR) competitors?
Q
What is the target price for Kymera Therapeutics (KYMR) stock?
A

The latest price target for Kymera Therapeutics (NASDAQ: KYMR) was reported by Wells Fargo on Wednesday, June 1, 2022. The analyst firm set a price target for 35.00 expecting KYMR to rise to within 12 months (a possible 68.84% upside). 13 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Kymera Therapeutics (KYMR)?
A

The stock price for Kymera Therapeutics (NASDAQ: KYMR) is $20.73 last updated June 27, 2022, 8:00 PM UTC.

Q
Does Kymera Therapeutics (KYMR) pay a dividend?
A

There are no upcoming dividends for Kymera Therapeutics.

Q
When is Kymera Therapeutics (NASDAQ:KYMR) reporting earnings?
A

Kymera Therapeutics’s Q2 earnings are confirmed for Friday, August 5, 2022.

Q
Is Kymera Therapeutics (KYMR) going to split?
A

There is no upcoming split for Kymera Therapeutics.

Q
What sector and industry does Kymera Therapeutics (KYMR) operate in?
A

Kymera Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.